" /> Cone-rod dystrophy 2 - CISMeF





Preferred Label : Cone-rod dystrophy 2;

Symbol : CORD2;

CISMeF acronym : CORD; CORD2; CRD; CRD2; RCRD2;

Type : Phenotype, molecular basis known;

Alternative titles and symbols : CRD2; RCRD2; Retinal cone-rod dystrophy; Cone-rod dystrophy; CRD; Cone-rod retinal dystrophy; CORD;

Description : Cone-rod dystrophy (CORD) characteristically leads to early impairment of vision. An initial loss of color vision and of visual acuity is followed by nyctalopia (night blindness) and loss of peripheral visual fields. In extreme cases, these progressive symptoms are accompanied by widespread, advancing retinal pigmentation and chorioretinal atrophy of the central and peripheral retina (Moore, 1992). In many families, perhaps a majority, atrophy of the central and peripheral chorioretinal atrophy is not found (Tzekov, 1998). - Genetic Heterogeneity of Autosomal Cone-Rod Dystrophy There are several other autosomal forms of CORD for which the molecular basis is known. CORD3 (604116) is caused by mutation in the ABCA4 gene (601691) on chromosome 1p21-p23. CORD5 (600977) is caused by mutation in the PITPNM3 gene (608921) on chromosome 17p13-p12. CORD6 (601777) is caused by mutation in the GUCY2D gene (600179) on chromosome 17p13.1.;

Inheritance : Autosomal dominant (19q13.1-q13.2);

Prefixed ID : #120970;

Détails


Vous pouvez consulter :


Nous contacter.
28/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.